Cadre (CDRE) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Q1 2026 net sales rose 19.5% year-over-year to $155.4 million, driven by acquisitions and strong demand in duty gear and armor, despite lower demand in some segments.
Orders backlog reached a record $355.4 million, up $166 million since year-end, reflecting new contracts, large EOD orders, and acquisitions.
Net income for Q1 2026 was $2.0 million ($0.05 per diluted share), down 78.6% from $9.2 million in Q1 2025 due to higher compensation, interest, and transaction expenses.
Adjusted EBITDA increased 3% to $21.1 million, with a margin of 13.6%.
Major acquisitions included TYR Tactical for $185.2 million in January and Alien Gear Holsters for $10.3 million in April.
Financial highlights
Gross profit for Q1 2026 was $60.2 million, up from $56.1 million year-over-year; gross margin declined to 38.7% from 43.1% due to inventory step-up amortization and product mix.
Adjusted EBITDA increased to $21.1 million from $20.5 million year-over-year, but margin fell from 15.8% to 13.6%.
Operating income for Q1 2026 was $7.5 million, down from $13.6 million year-over-year, impacted by higher SG&A, restructuring, and related party expenses.
Cash and cash equivalents at quarter-end were $41.3 million, down from $122.9 million at year-end, reflecting acquisition outflows.
Total debt rose to $365.8 million from $307.3 million at year-end 2025.
Outlook and guidance
Full-year 2026 net sales guidance: $736 million–$758 million; Adjusted EBITDA: $136 million–$141 million; capital expenditures: $10 million–$14 million.
Management expects continued growth from recent acquisitions, strong backlog, and attractive end markets, with 44% of remaining performance obligations to be recognized within 12 months.
Liquidity is considered sufficient for at least the next 12 months, supported by cash flows and available credit.
Latest events from Cadre
- Proxy covers director elections, auditor ratification, executive pay, and governance practices.CDRE
Proxy filing24 Apr 2026 - Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation23 Mar 2026 - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 202511 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Q2 net sales up 19% to $144.3M, adjusted EBITDA margin 19.6%, 2024 guidance unchanged post-cyber event.CDRE
Q2 20241 Feb 2026 - Stable demand, innovation, and operational focus drive growth and margin expansion.CDRE
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Cybersecurity incidents hit Q3, but record backlog and acquisitions support strong outlook.CDRE
Q3 202416 Jan 2026 - Strong market positions and strategic acquisitions drive growth in public safety and nuclear sectors.CDRE
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026